(Q34025829)

30 July 2017

Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma (English)

1 reference

30 July 2017

17

R Z Orlowski

1 reference

30 July 2017

L Yang

1

1 reference

30 July 2017

H Wang

2

1 reference

30 July 2017

S M Kornblau

3

1 reference

30 July 2017

D A Graber

4

1 reference

30 July 2017

N Zhang

5

1 reference

30 July 2017

J A Matthews

6

1 reference

30 July 2017

M Wang

7

1 reference

30 July 2017

D M Weber

8

1 reference

30 July 2017

S K Thomas

9

1 reference

30 July 2017

J J Shah

10

1 reference

30 July 2017

L Zhang

11

1 reference

30 July 2017

G Lu

12

1 reference

30 July 2017

M Zhao

13

1 reference

30 July 2017

R Muddasani

14

1 reference

30 July 2017

S-Y Yoo

15

1 reference

30 July 2017

K A Baggerly

16

1 reference

30 July 2017

language of work or name

English

0 references

publication date

8 November 2010

1 reference

30 July 2017

1 reference

30 July 2017

30

1 reference

30 July 2017

1329-1340

1 reference

30 July 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2010.515

30 July 2017

0 references

cites work

Unbiased screening for transcriptional targets of ZKSCAN3 identifies integrin beta 4 and vascular endothelial growth factor as downstream targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

The previously undescribed ZKSCAN3 (ZNF306) is a novel "driver" of colorectal cancer progression.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

Chromosome 6p amplification and cancer progression.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

Molecular pathogenesis and a consequent classification of multiple myeloma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

Differential myeloma cell responsiveness to interferon-alpha correlates with differential induction of p19(INK4d) and cyclin D2 expression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients

5 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.515

Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.515

Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.515

Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.515

Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.515

Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.515

A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endothelial cells of patients with multiple myeloma.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128235

Expression of VEGF and its receptors by myeloma cells

29 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.515

Multiple myeloma patients with CKS1B gene amplification have a shorter progression-free survival post-autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.515

Cytogenetic study in multiple myeloma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.515

Multiple myeloma primary cells show a highly rearranged unbalanced genome with amplifications and homozygous deletions irrespective of the presence of immunoglobulin-related chromosome translocations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.515

Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.515

Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.515

Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21057542

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2010.515

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference